ADMA (NASDAQ) - Dividend History and Outstanding Shares

No Dividends discovered - So far (until October 2024) ADMA does not pay dividends. Outstanding Shares evolving.

No Dividends
As of October 2024, ADMA Biologics (ADMA) does not pay a dividend.

Outstanding Shares

What is the Trend of ADMA`s Outstanding Shares?

The Outstanding Shares of ADMA Biologics are growing at a rate of 36.59% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 100.00%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did ADMA Biologics ever had a Stock Split?

No Stock Splits found.

Year Number of Shares (Mill.) Growth
2024 242.17 +7.17%
2023 225.97 +11.41%
2022 202.83 +12.18%
2021 180.81 +87.14%
2020 96.62 +62.88%
2019 59.32 +27.97%
2018 46.35 +2.29%
2017 45.32 +251.66%
2016 12.89 +20.32%
2015 10.71 +8.68%
2014 9.86 +6.06%
2013 9.29 +99.64%
2012 4.65 +86.17%
2011 2.5
2010 2.5
2009 2.5
2008 2.5 -99.9%
2007 2500
2006 2500

Dividend Yields, Growth & Consistency

Overall Dividend Rating -
Dividends Paid 12m - Yield 12m -
Payout Consistency - Yield on Cost 5y -
Growth Rate 5y - Correlation Rate 5y -
First Payout - Next Payout -
Compare ADMA Dividends with its Industry Peers

No Dividends Paid

-

  • ADMA`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price 20.29.
  • 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by the price 5 years ago).
  • The 0.0% Payout Consistency of ADMA Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
  • The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases ADMA`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to 100.
Ratings surpassing 50 are regarded as favorable, while those exceeding 75 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.